NAV 发表于 2025-3-23 12:47:25

Submitted on: 07 November 2001.
Revised on: 20 November 2001.
Accepted on: 27 November 2001.
LANCET ONCOLOGY---ELSEVIER SCIENCE INC

Ankylo- 发表于 2025-3-23 15:50:27

Submitted on: 10 March 1999.
Revised on: 02 April 1999.
Accepted on: 07 April 1999.
LANCET ONCOLOGY

喊叫 发表于 2025-3-23 21:33:08

http://reply.papertrans.cn/3/206/20503/20503-13.png

果仁 发表于 2025-3-23 23:49:33

Submitted on: 02 October 2017.
Revised on: 07 November 2017.
Accepted on: 29 November 2017.
LANCET ONCOLOGY---ELSEVIER SCIENCE INC

的阐明 发表于 2025-3-24 03:38:34

http://reply.papertrans.cn/3/206/20503/20503-15.png

歹徒 发表于 2025-3-24 09:51:45

http://reply.papertrans.cn/3/206/20503/20503-16.png

minion 发表于 2025-3-24 12:48:07

http://reply.papertrans.cn/3/206/20503/20503-17.png

骑师 发表于 2025-3-24 15:49:33

http://reply.papertrans.cn/3/206/20503/20503-18.png

未开化 发表于 2025-3-24 19:15:41

Submitted on: 12 October 2007.
Revised on: 01 November 2007.
Accepted on: 16 November 2007.
LANCET ONCOLOGY---ELSEVIER SCIENCE INC

Hirsutism 发表于 2025-3-24 23:11:55

http://reply.papertrans.cn/3/206/20503/20503-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊LANCET ONCOLOGY 2024/2025影响因子:41.615 (LANCET ONCOL) (1470-2045). (ONCOLOGY)(肿瘤学)Science Citation Index Expanded